Nexium Buyers Urge Judge To Rethink Ranbaxy Win In MDL
New evidence from the U.S. Food and Drug Administration shows that Ranbaxy Inc. could have received approval for a generic version of heartburn drug Nexium far sooner than it did, direct...To view the full article, register now.
Already a subscriber? Click here to view full article